Elevated ocular levels of vascular endothelial growth factor in patients with von Hippel-Lindau disease
Open Access
- 1 October 1997
- journal article
- clinical trial
- Published by Elsevier in Annals of Oncology
- Vol. 8 (10) , 1015-1022
- https://doi.org/10.1023/a:1008213320642
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Von Hippel‐Lindau SyndromeBrain Pathology, 1995
- Elevated Levels of an Angiogenic Peptide, Basic Fibroblast Growth Factor, in the Urine of Patients With a Wide Spectrum of CancersJNCI Journal of the National Cancer Institute, 1994
- VEGF/VPF: The angiogenesis factor found?Current Biology, 1993
- Interleukin-8 as a Macrophage-Derived Mediator of AngiogenesisScience, 1992
- Expression of basic fibroblast growth factor in human gastric carcinomasVirchows Archiv B Cell Pathology Including Molecular Pathology, 1992
- Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesisNature, 1992
- Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factorBiochemical and Biophysical Research Communications, 1992
- The fms -Like Tyrosine Kinase, a Receptor for Vascular Endothelial Growth FactorScience, 1992
- Hypoxia induces endothelin gene expression and secretion in cultured human endothelium.Journal of Clinical Investigation, 1991
- Vascular Endothelial Growth Factor Is a Secreted Angiogenic MitogenScience, 1989